Cargando…
Correlation between cognition and plasma noradrenaline level in Alzheimer’s disease: a potential new blood marker of disease evolution
Recent evidence showing degeneration of the noradrenergic system in the locus coeruleus (LC) in Alzheimer’s disease (AD) has motivated great interest in noradrenaline (NA) as a potential brain hallmark of the disease. Despite the current exploration of blood markers for AD, the deregulation of the p...
Autores principales: | Pillet, Laure-Elise, Taccola, Camille, Cotoni, Justine, Thiriez, Hervé, André, Karine, Verpillot, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335170/ https://www.ncbi.nlm.nih.gov/pubmed/32620743 http://dx.doi.org/10.1038/s41398-020-0841-7 |
Ejemplares similares
-
Correction: Correlation between cognition and plasma noradrenaline level in Alzheimer’s disease: a potential new blood marker of disease evolution
por: Pillet, Laure-Elise, et al.
Publicado: (2020) -
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
por: Gutiérrez, Irene L., et al.
Publicado: (2022) -
Noradrenaline and Parkinson's Disease
por: Delaville, Claire, et al.
Publicado: (2011) -
The Contribution of the Locus Coeruleus–Noradrenaline System Degeneration during the Progression of Alzheimer’s Disease
por: Mercan, Dilek, et al.
Publicado: (2022) -
Noradrenaline and Movement Initiation Disorders in Parkinson’s Disease: A Pharmacological Functional MRI Study with Clonidine
por: Criaud, Marion, et al.
Publicado: (2022)